Honeywell International Inc
$88.27B- Market cap
- $65.82B
- Debt
- +$34.94B
- Cash
- −$12.49B
Capital structure 65% equity / 35% debt · EV / Revenue 2.36x · EV proxy / EBITDA proxy 9.28x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HON stock price at discount vs EMR $207.66 current versus $265.67 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EMR's multiple
Implied fair value · at HON's multiple
Snapshot Sep 16, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 65% equity / 35% debt · EV / Revenue 2.36x · EV proxy / EBITDA proxy 9.28x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 86% equity / 14% debt
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Honeywell International Inc · implied price per share
Bear
$67.83
Base
$87.37
Bull
$114.31
EMERSON ELECTRIC CO. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe HON can reaccelerate growth while sustaining its current margin and ROIC profile, then a modest accumulation makes sense because the stock is below the P/E-implied value and near the historical range; if not, the DCF range and weaker growth argue for caution.
HON trades at $243.05 versus a P/E-implied value of $272.94, suggesting 12.3% upside. The stock is also below EMR-implied range midpoint and sits near the low end of its historical band, but the DCF range is meaningfully lower, which weakens the strength of the upside case.
Supporting Metrics